Medical SpecialtyOpen Access

Retrospective evaluation of hematopoetic stem-cell transplantation in primary immunodeficiency disorders

Is this your thesis?

This record came from a bulk archive import. If it’s yours, link it to your profile.

2017
0 views
0 downloads

Abstract (EN)

Introduction and Objective: Primary immunodeficiency disorders (PID) are inherited diseases characterized by impairment of innate or adaptive immunity, leading to recurrent infections, autoimmunity, allergy and susceptibility to malignancy. Early diagnosis and treatment are life-saving in primary immunodeficiency diseases. Hematopoetic stem cell transplantation (HSCT) is a curative treatment for many diseases in this group. Especially severe combined immunodeficiencies are pediatric emergent diseases, and when it is suspected, patients should rapidly be referred to tertiary care centers where HSCT are available. In this study, it was aimed to analyze the clinical and immunological data and immune reconstitution of 57 PID patients that had undergone HSCT. Materials and Methods: The study population was composed of 57 patients who were followed up by Pediatric Immunology and Pediatric Stem Cell Transplantation Departments, Ege University Faculty of Medicine between August 1998 and January 2017. Patients were classified according to 2015 IUIS primary immunodeficiencies classification. Patients were classified in three main groups such as SCID (severe combined immunodeficiency disease), non-SCID combined immunodeficiencies (CID) and other primary immunodeficiencies (other-PID). SCID patients were grouped as T-B-NK+, T-B+ NK+, and T-B+NK- according to their immune phenotypes. T+ combined immunodeficiencies (leaky SCID), DOCK8 deficiency, CD40 deficiency, CD40L deficiency, Artemis deficiency, MHC class 2 deficiency, ZAP70 deficiency, Omenn syndrome, Purine nucleoside phosphorylase deficiency and Wiskott-Aldrich syndrome constituted non-SCID combined immunodeficiency group. Chronic granulomatous disease, Chediak Higashi syndrome, Griscelli syndrome, Interferon-gamma receptor 1 complete defect, IL10 receptor defect and common variable immunodeficiency subjects were grouped as other-PIDs. Information about the demographic features, diagnosis, follow-up period, treatment strategies, transplantation procedures, complications and outcome of HSCT were vii collected from medical files. Statistical analysis was performed with IBM SPSS statistics 23 program. Results : Median age on admission and age at diagnosis age was lower in SCID group and there was a statistically significant difference among disease groups (p=0.03 and p=0.04, respectively). The most common complaint was the recurrent respiratory infections. Growth failure was more prevalent in the SCID group (p=0.048) and the recurrent abscess was mostly observed in the other PID group (p=0.001). Initial laboratory findings, such as leucocyte, absolute neutrophil and lymphocyte counts, IgG, IgM, IgA levels, and lymphocyte subsets were lower in SCID group (p<0.005). Mycobacterial infections were more common in the other- PID group and CMV infection was commonly seen in CID group (p=0.001). Age at HSCT, and the follow-up period between diagnosis and transplantation was shorter in SCID patients (p<0.001). Eleven SCID patients did not received conditioning regimen, 37 patients had myeloablative, 4 had non-myeloablative protocol, and 5 had RIC (Reduced Intensity Conditioning) conditioning protocol. Median time to neutrophil engrafment was 16 days in 41 patients (71.9%), and it was 24 days in 32 patients (55.4%) for the thrombocyte engrafment. Five out of 8 patients with BCGrelated complication after transplantation were in SCID group (p=0.018). Considering 1st, 2nd and 12th month chimerism values according to the disease groups, 1st and 12th month chimerism ratios were found to be statistically lower in SCID group (p<0.05). There was no statistically significant difference between the ratios of CD3+ T cells, CD19+B cells, CD3-CD16+/56+ natural killer cells (NK) checked on 1, 2 and 12 months after HSCT (p>0.05). The median age of diagnosis age in SCID group (p=0.008), the median age of transplantation (p=0.007), the median interval between the diagnosis and transplantation (p=0.036) were found to be shorter in surviving SCID patients than deceased ones. A statistically significant difference was found between the alive and deceased patients in terms of chronic lung disease before transplantation (p=0.024), malnutrition (p=0.008). Lung infections were the most common cause of death after HSCT. Overall survival was 89.5% in MSD group, 75% in MRD group, and 58.3% in MUD group; all of MMRD transplants were all lost. Conclusion: In terms of the ongoing utility of HSCT, it will remain the mainstay of correcting severe PIDs in Turkey. Despite significant pre-HSCT morbidity from the underlying PID in our patients (malnutrition, chronic lung disease, CMV infection), viii the outcome of our patients is satisfactory. Efforts to educate primary care physicians on early diagnosis and efoorts to implement newborn screening in our country might result in better survival rates in PID patients.

Author

Gülşah Kılbaş

How to Cite

Gülşah Kılbaş (Medical Specialty Thesis). Retrospective evaluation of hematopoetic stem-cell transplantation in primary immunodeficiency disorders, 2017, Ege University.

Keywords

License

Tüm Hakları Saklıdır

This work is shared under the specified license terms.

More theses from Ege University